Metronidazol Aurovitas

Metronidazole, the active ingredient in Metronidazol Aurovitas, is a nitroimidazole antibiotic presented as an oral dosage form for systemic use. It treats infections caused by anaerobic bacteria and certain protozoa in adult and pediatric patients as prescribed by a healthcare professional.

GNH USA supplies Metronidazol Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazol Aurovitas is indicated for infections where anaerobic bacteria or susceptible protozoa are involved.

- Bacterial vaginosis: restores normal vaginal flora by eradicating anaerobic pathogens. - Trichomoniasis: eliminates Trichomonas vaginalis, relieving symptoms and preventing transmission. - Amoebiasis: treats intestinal Entamoeba histolytica infection, reducing dysentery. - Giardiasis: clears Giardia lamblia from the gastrointestinal tract. - Anaerobic bacterial infections (including Clostridioides difficile): controls toxin‑producing anaerobes in the gut and other sites.

Metronidazol Aurovitas may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient alteration of taste perception. - Diarrhea: loose stools that may be self‑limiting. - Headache: mild to moderate cranial discomfort.

Serious or Rare Side Effects: - Seizures: convulsive episodes requiring immediate medical attention. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: serious skin and mucous membrane disorder. - Pseudomembranous colitis: severe colonic inflammation. - Hepatotoxicity: elevated liver enzymes or liver injury.

Before prescribing Metronidazol Aurovitas, clinicians should consider several safety factors.

- Renal function: assess kidney status, especially in patients with impairment. - Hepatic function: evaluate liver health, as metabolism occurs hepatically. - Alcohol consumption: advise avoidance of alcohol to prevent disulfiram‑like reactions. - Pregnancy status: weigh benefits against potential risks; use only if clearly needed. - Superinfection risk: monitor for overgrowth of non‑susceptible organisms. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Metronidazol Aurovitas can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, nausea, and tachycardia. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: can raise lithium levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Phenytoin: may reduce metronidazole concentrations, decreasing effectiveness. - Cimetidine: can increase metronidazole plasma levels, heightening adverse effects.